ICU Medical Inc. (ICUI) Director Sells $210,900.00 in Stock
ICU Medical Inc. (NASDAQ:ICUI) Director Richard Md Sherman sold 1,500 shares of ICU Medical stock in a transaction dated Thursday, October 6th. The stock was sold at an average price of $140.60, for a total value of $210,900.00. Following the transaction, the director now directly owns 70,699 shares in the company, valued at $9,940,279.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Richard Md Sherman also recently made the following trade(s):
- On Monday, September 19th, Richard Md Sherman sold 3,000 shares of ICU Medical stock. The stock was sold at an average price of $122.51, for a total value of $367,530.00.
ICU Medical Inc. (NASDAQ:ICUI) opened at 149.65 on Friday. ICU Medical Inc. has a 52 week low of $85.56 and a 52 week high of $150.37. The company has a 50-day moving average price of $126.14 and a 200-day moving average price of $112.44. The stock has a market cap of $2.41 billion, a PE ratio of 44.57 and a beta of 0.37.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/08/icu-medical-inc-icui-director-sells-210900-00-in-stock.html
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Monday, August 8th. The company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.10. The company had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. ICU Medical had a return on equity of 10.33% and a net margin of 14.94%. The business’s revenue was up 15.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.97 earnings per share. Analysts anticipate that ICU Medical Inc. will post $4.54 earnings per share for the current year.
A number of brokerages recently weighed in on ICUI. Piper Jaffray Cos. reissued a “neutral” rating and issued a $119.00 price target (up previously from $115.00) on shares of ICU Medical in a research note on Thursday, August 11th. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price target on the stock in a research note on Friday, August 12th.
Institutional investors have recently bought and sold shares of the company. Virginia Retirement System acquired a new position in ICU Medical during the first quarter worth approximately $333,000. Teachers Advisors Inc. raised its position in ICU Medical by 13.3% in the first quarter. Teachers Advisors Inc. now owns 202,753 shares of the company’s stock worth $21,107,000 after buying an additional 23,812 shares in the last quarter. JPMorgan Chase & Co. raised its position in ICU Medical by 63.5% in the first quarter. JPMorgan Chase & Co. now owns 185,078 shares of the company’s stock worth $19,267,000 after buying an additional 71,891 shares in the last quarter. Menta Capital LLC raised its position in ICU Medical by 157.1% in the first quarter. Menta Capital LLC now owns 5,400 shares of the company’s stock worth $562,000 after buying an additional 3,300 shares in the last quarter. Finally, M&T Bank Corp raised its position in ICU Medical by 3.3% in the first quarter. M&T Bank Corp now owns 2,117 shares of the company’s stock worth $220,000 after buying an additional 67 shares in the last quarter. 89.50% of the stock is currently owned by institutional investors.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.